The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: N acetyl cysteine Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: Linezolid 600 mg Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: N acetyl cysteine Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: Linezolid 600 mg Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: N acetyl cysteine Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: Linezolid 600 mg Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: N acetyl cysteine Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: Linezolid 600 mg Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: N acetyl cysteine Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: Linezolid 600 mg Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: N acetyl cysteine Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
Condition:   Thrombocytopenia; Drugs Intervention:   Drug: Linezolid 600 mg Sponsor:   Helwan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials

The Effect of N-acetylcysteine in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
Condition:   Linezolid Induced Thrombocytopenia Intervention:   Drug: N acetyl cysteine Sponsor:   Helwan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2023 Category: Research Source Type: clinical trials